Rekvina Laboratories Limited (BOM:526075)
India flag India · Delayed Price · Currency is INR
29.31
-0.59 (-1.97%)
At close: Mar 10, 2026

Rekvina Laboratories Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2020 - 2016
Revenue
5.42-----
Upgrade
Gross Profit
0.33-----
Upgrade
Selling, General & Admin
2.010.45----
Upgrade
Other Operating Expenses
0.690.930.160.040.750.64
Upgrade
Operating Expenses
2.71.370.160.040.750.64
Upgrade
Operating Income
-2.37-1.37-0.16-0.04-0.75-0.64
Upgrade
Other Non Operating Income (Expenses)
----0-0.03-
Upgrade
EBT Excluding Unusual Items
-2.37-1.37-0.16-0.05-0.79-0.64
Upgrade
Other Unusual Items
---0.04--
Upgrade
Pretax Income
-2.37-1.37-0.16-0.01-0.79-0.64
Upgrade
Net Income
-2.37-1.37-0.16-0.01-0.79-0.64
Upgrade
Net Income to Common
-2.37-1.37-0.16-0.01-0.79-0.64
Upgrade
Shares Outstanding (Basic)
66666-
Upgrade
Shares Outstanding (Diluted)
66666-
Upgrade
Shares Change (YoY)
0.41%---0.66%--
Upgrade
EPS (Basic)
-0.38-0.23-0.03-0.00-0.13-
Upgrade
EPS (Diluted)
-0.39-0.23-0.03-0.00-0.13-
Upgrade
Gross Margin
6.05%-----
Upgrade
Operating Margin
-43.74%-----
Upgrade
Profit Margin
-43.74%-----
Upgrade
EBIT
-2.37-1.37-0.16-0.04-0.75-0.64
Upgrade
EBIT Margin
-43.74%-----
Upgrade
Revenue as Reported
5.42--0.04--
Upgrade
Advertising Expenses
-0.02----
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.